Fig. 3
From: GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer
Clarifying GAD1 as a key prognostic gene in prostate cancer. A Overall survival analysis of GAD1. B–F GAD1 and clinicopathological features of prostate cancer, including T stage, N stage, Primary therapy outcome, PSA and Gleason score. G Time dependent ROC curve analyses. H Calibration curves of nomogram on consistency between predicted and observed 1-, 3-, and 5-year survival. I Nomogram for predicting 1-, 3-, and 5-year PFI in the entire TCGA cohort